Full-Time

Manager - Clinical Pharmacist

Posted on 4/18/2026

Tennessee Oncology

Tennessee Oncology

501-1,000 employees

Community-based cancer care with clinical research

No salary listed

Murfreesboro, TN, USA

In Person

Category
Medical, Clinical & Veterinary (1)
Required Skills
Inventory Management
Data Analysis
Requirements
  • Doctor of Pharmacy (PharmD) required.
  • Current, active, and unrestricted pharmacy license in Tennessee.
  • Minimum of 5 years of pharmacy experience, with at least 3 years in a clinical or health system-based setting or completion of a PGY-1 or PGY-2 residency (or equivalent clinical experience).
  • In-depth understanding of pharmacotherapy and clinical decision-making in a multidisciplinary care environment.
  • Ability to assess medication therapy plans and develop patient-specific recommendations.
  • Strong leadership and coaching skills with experience managing clinical teams.
  • Effective in building relationships and collaborating with physicians, nurses, and administrative teams.
  • Proficient in quality improvement methodologies and clinical documentation standards.
  • Skilled in interpreting data to guide clinical and operational strategy.
  • Excellent written and verbal communication skills, especially in clinical and educational contexts.
  • Knowledge of pharmacy regulations, accreditation standards, and compliance frameworks (e.g., USP <797>/<800>).
Responsibilities
  • Provide direct oversight of clinical pharmacy operations including the review, preparation, compounding, and dispensing of medications, with a focus on patient-centered therapeutic outcomes.
  • Serve as a clinical resource to healthcare providers and patients, offering expert consultation on drug therapy, indications, contraindications, pharmacokinetics, interactions, and side effects.
  • Support evidence-based prescribing through active collaboration with medical staff and involvement in clinical decision-making.
  • Oversee the development and implementation of clinical protocols and therapeutic guidelines in alignment with organizational goals and national standards.
  • Ensure compliance with all federal, state, and accrediting body regulations, including USP standards, CMS requirements, and pharmacy-specific policies.
  • Monitor and manage pharmacy inventory to ensure safe and cost-effective medication use, minimizing waste and enhancing formulary adherence.
  • Lead clinical quality initiatives, medication use evaluations, and performance improvement projects; track and report outcomes to leadership.
  • Promote and maintain a culture of safety, accuracy, and accountability across all pharmacy operations and staff activities.
  • Provide regular performance feedback, conduct evaluations, and ensure continuous training and clinical development for pharmacy staff.
  • Facilitate interdepartmental collaboration to improve transitions of care, medication reconciliation, and patient education.
  • Use data to analyze pharmacy performance, financial impact, and outcomes; prepare and present operational and clinical reports to leadership.
  • Ensure timely and accurate documentation of clinical interventions, adverse events, and quality measures.
  • Oversee pharmacy participation in Quality Improvement Programs, audits, and compliance initiatives.
  • Precept pharmacy interns and residents, supporting clinical education and workforce development.
  • Actively participate in Pharmacy & Therapeutics (P&T) Committee decisions and support the implementation of formulary changes and medication-use policies.
  • On call responsibilities as needed.
  • Perform other duties as assigned by management.

Tennessee Oncology runs a large network of community-based cancer care with a strong clinical-trial program. It delivers cancer treatment at local clinics, including on-site chemotherapy, and uses molecular diagnostics to tailor therapies to each patient’s cancer. The organization supports patients with its in-house Park Pharmacy, which stocks oncology and hematology medications and handles insurance, prior authorizations, co-pays, and 24/7 pharmacist access. It differentiates itself by combining extensive community-based care with a sizable research network and a partnership with OneOncology, enabling broad access to trials and advanced care at convenient locations. The goal is to provide high-quality cancer care and access to clinical research close to patients’ homes.

Company Size

501-1,000

Company Stage

Debt Financing

Total Funding

$98.3M

Headquarters

Nashville, Tennessee

Founded

1976

Simplify Jobs

Simplify's Take

What believers are saying

  • Opened Johnson City clinic November 5, 2024, staffed by Drs. Maatouk and Lord.
  • Partnered with OncoveryCare post-$4.5M funding for survivorship care model.
  • Launched rural telehealth program in Dickson and Robertson Counties.

What critics are saying

  • Ascension's Drs. Waynick and Mitchell steal Tullahoma patients within 6-12 months.
  • SOPHiA GENETICS rivals erode precision medicine edge in 12-24 months.
  • One Oncology acquires practices, forcing Tennessee Oncology sale in 12-18 months.

What makes Tennessee Oncology unique

  • Tennessee Oncology integrates medical oncology, radiation oncology, and imaging at Tullahoma center.
  • Appointed Dr. Casey Chollet-Lipscomb as Chief Medical Officer on March 10, 2025.
  • Expanded SOPHiA GENETICS partnership for precision medicine across 36 clinics.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Paid Vacation

Flexible Work Hours

Company News

Tennessee Oncology
Sep 24th, 2025
Tennessee Oncology Breaks Ground on State-of-the-Art Medical Center in Tullahoma

Tennessee Oncology breaks ground on state-of-the-art Medical Center in Tullahoma. Tennessee Oncology recently broke ground a new state-of-the-art medical center in Tullahoma. Located on a three-acre campus, the 33,000 square foot center will bring together medical oncology, radiation oncology, and imaging services - offering patients comprehensive, coordinated cancer care in one location, close to home. "The official groundbreaking of the Tullahoma Medical Center is more than the start of construction - it is a continuation of a mission, a vision, and a legacy of compassionate care for the Tullahoma community," said Natalie Dickson, MD, President and CEO of Tennessee Oncology. "This new facility represents a bold step forward for Tullahoma. Together, with Dr. Ryan Carr, Dr. Nnamdi Eze, Dr. John Phillips, Dr. Brian Schlick, and Dr. Mark Sittig, we are laying the foundation for something that will make a lasting impact. This center will not only provide critical care to patients, but it will also stand as a symbol of hope, healing, and the enduring strength of this community." The Tullahoma Medical Center is a continuation of the incredible legacy of Dr. Mainuddin Ahmed and Dr. Adil Mohyuddin, whose commitment to oncology care in the Tullahoma region laid the foundation for the care Tnoncology provide patients today. This new medical center represents the heart of its mission at Tennessee Oncology - bringing world-class cancer care closer to the communities that need it most. Its investment in the Tullahoma Medical Center reflects its commitment to expanding access, supporting local patients, and delivering compassionate care where it matters. Tennessee Oncology extends a sincere thank-you to Jason Quick, the Tullahoma City Administrator, and Kathryn Wiseman of the Tullahoma Area Chamber of Commerce. Their dedication to the community and support of this project have been instrumental.

PR Newswire
Mar 10th, 2025
Tennessee Oncology Appoints Dr. Casey Chollet-Lipscomb As Chief Medical Officer

NASHVILLE, Tenn., March 10, 2025 /PRNewswire/ -- Tennessee Oncology, a nationally recognized independent oncology practice that treats nearly half of the cancer patients in the state across 36 clinics, is pleased to announce the appointment of Casey Chollet-Lipscomb, MD, as its new Chief Medical Officer

PR Newswire
Dec 3rd, 2024
Oneoncology Partner Practice Investigators To Present 26 Abstracts At Ash Annual Meeting

NASHVILLE, Tenn., Dec. 3, 2024 /PRNewswire/ -- OneOncology, a physician-led platform dedicated to advancing independent community oncology practices, and the OneOncology Research Network (OneR), its clinical research site management organization, proudly recognize the outstanding research contributions of its partner practice investigators from The Cancer and Hematology Centers in Michigan, New York Cancer Blood Specialists and Tennessee Oncology, who will showcase a total of 26 oral and poster presentations at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, taking place December 7–10, 2024

Impact Newswire
Nov 22nd, 2024
SOPHiA GENETICS Announces Expanded Partnership with Tennessee Oncology

SOPHiA GENETICS announces expanded partnership with Tennessee Oncology.

PR Newswire
Nov 5th, 2024
Tennessee Oncology Expands Cancer Care With New Clinic In Johnson City

NASHVILLE, Tenn., Nov. 5, 2024 /PRNewswire/ -- Tennessee Oncology, a nationally recognized independent oncology practice that cares for nearly half of Tennessee's cancer patients across 36 locations, proudly announces the opening of its new cancer care center in Johnson City. The clinic will be staffed by Jamal Maatouk, MD, Teresa Lord, MD, and a dedicated 30-member care team. "Expanding access to cancer care in Johnson City enables Tennessee Oncology to deliver world-class cancer treatment to the Tri-Cities region, eliminating the need for patients to travel long distances for the same high-quality care as they would receive in Nashville or Chattanooga," said Natalie Dickson, MD, President and Chief Executive Officer of Tennessee Oncology. "We are thrilled to welcome Dr. Maatouk and Dr

INACTIVE